Bioiberica, S.a.

Francesc Flores Salgado

Ramon Ruhi Roura

Francisco Javier Vila Pahi

Narc&iacute;s Arnau Pastor

The invention relates to novel disaccharides of formula (I), wherein R is selected from the group consisting of hydrogen, linear or branched (C -C ) alkyl, phenylalkyl with less than ten carbon atoms and &mdash;COCH ; R is selected from the group consisting of hydrogen, &mdash;COCH and SO M; R is selected from the group consisting of hydrogen, linear or branched (C -C ) alkyl, phenylalkyl with less than ten carbon atoms, &mdash;COCH and y &mdash;COPh, Ph being phenyl; G is selected from amongst &mdash;COOR and &mdash;COOM, R is selected from the group consisting of hydrogen, (C -C )-alkyl and arylalkyl with less than sixteen carbon atom; A is selected from the group consisting of hydrogen, &mdash;SO H, &mdash;SO M and &mdash;COCH ; B is selected from the group consisting of hydrogen, &mdash;SO H, &mdash;SO M and &mdash;COCH , wherein either A or B are necessarily either &mdash;SO H or &mdash;SO M, M being a an organic or metallic cation. Said compounds can be used as anti-arthritic agents, anti-inflammatory agents or to control blood coagulation.

Growing community of inventors

Mataro, Spain

Francesc Flores Salgado